Therapeutic drug monitoring
Delayed Elimination Concentrations of High-Dose Methotrexate in Adults With Hematological Malignancies: To Standardize or Not? A Scoping Review.
Fauziah T, Ai Sim Goh, Noraida Mohamed Shah, Mohd Makmor-Bakry, Shamin Mohd Saffian
Published: 202510.1097/FTD.0000000000001401
Abstract
BACKGROUND: High-dose methotrexate (HDMTX) is a cornerstone therapeutic regimen for hematological malignancies; however, delayed elimination remains a significant clinical challenge. Currently, no standardized definition for delayed elimination exist…
Preview only. Read the full abstract at the source